Related references
Note: Only part of the references are listed.Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer
Jennifer S. Temel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Lazarus Response in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation
Corey J. Langer
JOURNAL OF CLINICAL ONCOLOGY (2009)
First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
Akira Inoue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Analysis of observational studies in the presence of treatment selection bias - Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods
Therese A. Stukel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer
Robin Matsuyama et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Looking back from death: The value of retrospective studies of end-of-life care
CC Earle et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification in administrative databases of women dying of breast cancer
B Gagnon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology
Eva Grunfeld et al.
PALLIATIVE MEDICINE (2006)
Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer
Jose R. Murillo et al.
ONCOLOGIST (2006)
Evaluating claims-based indicators of the intensity of end-of-life cancer care
CC Earle et al.
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2005)
Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States
JE Wennberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Trends in the aggressiveness of cancer care near the end of life
CC Earle et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Resurrecting treatment histories of dead patients - A study design that should be laid to rest
PB Bach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
A systematic review of physicians' survival predictions in terminally ill cancer patients
P Glare et al.
BRITISH MEDICAL JOURNAL (2003)
Chemotherapy use among medicare beneficiaries at the end of life
EJ Emanuel et al.
ANNALS OF INTERNAL MEDICINE (2003)
Identifying potential indicators of the quality of end-of-life cancer care from administrative data
CC Earle et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis
CC Earle et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Who gets chemotherapy for metastatic lung cancer?
CC Earle et al.
CHEST (2000)
Share Paper
